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Abstract
Background: Intravenous lipid emulsions have been introduced for the management of patients with Local
Anesthetic Systemic Toxicity (LAST). These emulsions have been stated as a first-line treatment in the guidelines of
several international anesthesia organizations. Nevertheless, the adoption of lipid rescue therapy by Chinese
practitioners remains unknown. We, therefore, evaluated the current approaches to treat LAST and the use of
lipid rescue therapy among anesthesiologists in China.
Methods: In September 2013, a 23-question survey on regional anesthesia practice and availability of lipid emulsions
was sent by e-mail to directors or designated individuals at 41 academic anesthesiology departments listed by the
orthopedic anesthesia group of the Chinese Society of Anesthesiology.
Results: Responses were received from 36 of the 41 (88 %) anesthesiology departments. To simplify the analysis,
responses were divided into two groups according to the annual percentage of patients who received regional
anesthesia (RA) for orthopedic anesthesia: 14 departments (39 %) with high-utilization (≥50 %) and 22 departments
(61 %) low-utilization (<50 %) of RA. Ropivacaine and bupivacaine were the common drugs used for RA, which were
independent of RA utilization. Interestingly, ultrasound-guided techniques were much more frequently used in
low-utilization institutions than in high-utilization institutions (P = 0.025). Lipid emulsion was readily available in
8 of the 36 (22 %) responding institutions, with 7 of the other 28 (25 %) institutions planning to stock lipid
emulsion. No differences in lipid availability and storage plans were observed between high- and low-utilization
institutions. Lipid resuscitation was performed in five of the eight departments that had lipid emulsion. Eleven patients
were successfully resuscitated and one was not.
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Conclusion: Lipid emulsion is not widely available in China to treat LAST resulted from RA for orthopedic patients.
Efforts are required to promote lipid rescue therapy nationwide.
Trial registration: Chinese Clinical Trail Registry (Registration number # ChiCTR-EOR-15006960; Date of Retrospective
Registration on August 23rd, 2015) http://www.chictr.org.cn/showproj.aspx?proj=11703.
Keywords: Local anesthetic systemic toxicity, Lipid rescue therapy, Survey
Background
The increased use of regional anesthesia (RA) have
increased the incidence of local anesthetic systemic
toxicity (LAST), which has been reported to range
from 7.5 to 20 per 10,000 peripheral nerve blocks
(PNBs) and at about 4 per 10,000 epidural blocks [1].
Although it is rare, LAST can be lethal. Many case
reports [2–5] and animal studies [6, 7] have suggested
that lipid emulsion infusion is effective in reversing
LAST, resulting in the use of lipid rescue therapy
(LRT) during resuscitation.
LRT has been explicitly supported by the Association
of Anesthetists of Great Britain and Ireland (AAGBI),
the American Society of Regional Anesthesia (ASRA),
and the American Heart Association (AHA) guidelines
on LAST treatment [8–10]. In addition, the American
College of Medical Toxicology (ACMT) has issued in-
terim aguidelines for the use of LRT in conditions other
than LAST [11]. Similar national guidelines have not yet
been introduced, but are under consideration, in China.
In 2006, a questionnaire study documented contempor-
ary practice strategies among academic anesthesiology
departments in the United States [12]. Two other na-
tional surveys, one in the United Kingdom in 2007
[13] and the other in the United States in 2011 [14],
have assessed the availability of lipid emulsion in ob-
stetric anesthesia units. Similarly, the availability of
and use of lipid rescue therapy in England and Wales
was also surveyed in 2009 [15]. To date, however, no
comparable survey has been completed in China. The
aim of this study was to evaluate the current status
of RA practices and the adoption of LRT among an-
esthesiologists in China.
Methods
This study was approved by the independent ethical
committee of Peking University Third Hospital, Beijing,
China (Approval No. 2013046). It was also registered
with Chinese Clinical Trial Registry under the number
ChiCTR-EOR-15006960. The approved questionnaire
was developed by three of the investigators (ZQL, MX
and SLJ), based on previous research [12–15] and the
guidelines published by the AAGBI and ASRA [8, 10].
The questionnaire consisted of 23 questions about the
current RA practices and the availability of lipid emulsions
in 2013. The survey responses were subsequently reviewed
by four orthopedic anesthesiologists (XYG, XLW, LZ and
ZGF) and an expert in LRT (XZX). The approved ques-
tionnaire is attached in Additional file 1.
The electronic questionaire was e-mailed to the 41
committee members of the orthopedic anesthesia
group of the Chinese Society of Anesthesiology (CSA)
on September 1st, 2013. Two follow-up e-mail reminders
at 1-month intervals were sent to non-responders.
December 1st, 2013 was the deadline to receive the feed-
back e-mails. Participation in this study was voluntary.
Completion of the survey indicated a consent to study
participation.
The respondents were grouped by the number of RA
performed in patients undergoing orthopedic anesthesia
per year, and we arbitrarily defined high-utilization insti-
tutions as those performing ≥ 50 % each year, and low-
utilization institutions as < 50 % each year. Descriptive
statistics were calculated. Fisher’s exact t-test was used
for between-group comparisons. All statistical analysis
was performed with SPSS for Windows (version 16.0;
SPSS, Chicago, IL). A p < 0.05 was considered statisti-
cally significant.
Results
Survey response and RA utilization
Responses were received from 36 out of the 41 (88 %)
anesthesiology departments; their characteristics are
shown in Table 1. Out of the 36 institutions, 14 (39 %)
used RA for orthopedic anesthesia in ≥ 50 % of patients
per year and 22 (61 %) used RA for < 50 % of these pa-
tients. RA included PNBs, epidural blocks and spinal
anesthesia.
RA practice
RA was performed and monitored in the operating
room of 29 (81 %) institutions, the RA induction area
of 4 (11 %) institutions, and the postanesthesia care
unit of 3 (8 %) institutions. With respect to the pre-
ferred local anesthetic when performing RA, 29
(81 %) respondents preferred ropivacaine and 6
(17 %) selected bupivacaine. There were 5 (14 %)
responding departments selected multiple drugs as
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the preferred anesthetics. So the summation of all
percentages exceeded 100 % (Fig. 1).
When performing RA, especially PNBs, almost all of
the institutions stated that monitoring consisted of pulse
oxygen saturation, noninvasive arterial blood pressure,
and electrocardiogram. Only one institution reported
that only pulse oxygen saturation was monitored during
regional blocking. The distribution of the average num-
ber of PNBs performed monthly was shown in Table 2.
In addtion, PNBs was performed by attending anesthesiol-
ogists at 28 (78 %) institutions and by senior anesthesiology
residents at only 8 (22 %) institutions.
Regional blocking was performed under ultrasound
guidance at 7 (19 %) institutions, under nerve stimulator
guidance at 12 (33 %) institutions, under both tech-
niques at 10 (28 %) institutions, and using landmark-
based techniques at 7 (19 %) institutions. Interestingly,
the use of ultrasound guidance by high- and low-
utilization institutions differed significantly (21 % vs.
64 %, P = 0.019, Fig. 2).
Incidence of LAST
Of the 36 responding institutions, 27 (75 %) reported an
incident of LAST in 2013, among which, 14 respondents
were high-utilization institutions while 13 respondents
were low-utilization institutions. The incidence of LAST
in the high-utilization institutions was much higher
than that in the low-utilization institutions (100 % vs.
59 %, P = 0.006). The distribution of LAST among
techniques used was: epidural anesthesia (31 %), brachial
plexus block (50 %), cervical plexus block (23 %), lumbar
plexus block (8 %), sciatic nerve block (4 %), combined
lumbar and sciatic nerve block (31 %), and others (8 %).
Although 34 institutions (94 %) reported having an al-
gorithm or guideline for the treatment of LAST, only the
algorithms of 11 (31 %) of these institutions included
lipid emulsions for treatment. All 36 responding insti-
tutions reported using lidocaine to detect intravascu-
lar epidural catheter placement, with five (14 %)
adding epinephrine to the lidocaine.
Adoption of lipid rescue
When respondents were asked about the adoption of
LRT for management of LAST, 22 (61 %) knew that lipid
emulsion infusion was a treatment option and 13 (36 %)
had heard of LRT but did not know the specifics of the
regimen. Eight institutions (22 %) were aware of the
2007 and 2010 AAGBI guidelines for LAST manage-
ment [16, 17], 19 (53 %) were aware of the 2010 ARSA
guidelines [8], and two (6 %) were aware of the 2011
ACMT guidelines [11].
Lipid emulsion: availability and choice
Lipid emulsion was readily available in 8 of the 36
(22 %) responding institutions (Fig. 3a). This availability
was not associated with RA utilization (Fig. 3b). These
eight institutions began to stock lipid emulsion between
2008 and 2012, with all eight institutions reporting stor-
ing lipid emulsion according to AAGBI [16, 17] and
ASRA guidelines [8].
Of the 28 departments that did not currently stock lipid
emulsion, seven (25 %) planned to stock it. The reasons
for the remaining 21 departments that did not plan to
stock lipid emulsion are shown in Table 3, with some de-
partments citing more than one reason. In addition, high-
and low-utilization institutions were similarly unlikely in
planning to store lipid emulsion (Fig. 3c).
The most common storage locations for lipid emulsion
were anesthesia preparation rooms (4/8, 50 %) and a
pharmacy within the department (3/8, 38 %). One re-
spondent reported storing lipid emulsion in the posta-
nesthesia care unit. All eight, however, reported that
Table 1 Characteristics of responding institutions
Hospital characteristics Median (interquartile values)
Orthopaedics surgery (patient per year) 4000 (2500–7200)
Spine surgery 1000 (500–2000)
Upper and lower limb surgeries 2500 (1500–4800)
Percentage of orthopaedics surgeries
performed under RA
30 % (16 %-70 %)
RA regional anesthesia, includes peripheral nerve blocks, epidural and
spinal blocks
Fig. 1 Long-acting local anesthetics preferred by responding institutions
Table 2 Distribution of the average number of PNBs performed
monthly in 2013
Number of PNBs n (%)
0-10 4 (11 %)
11-30 6 (17 %)
31-60 14 (39 %)
>60 12 (33 %)
PNBs, peripheral nerve blocks
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they could obtain the emulsion within 5 min for emer-
gency treatment of LAST.
Of the eight units, five stocked lipid emulsions con-
taining long-chain triglycerides (e.g. Intralipid; Huarui
Pharmaceuticals Co., Ltd., Wuxi, China), two stocked
lipid emulsions containing long- and medium-chain
triglycerides (e.g. Lipovenoes; Huarui Pharmaceuticals
Co., Ltd.); and one stocked both. Five of the eight units
(63 %) reported using lipid emulsion to treat LAST
within their departments. Of the 12 patients treated, 11
were successfully resuscitated; whereas one was not,
making the overall failure rate of lipid resuscitation for
LAST at 8.3 %.
Resuscitation practice
When asked about treatment of ventricular tachycardia
from presumed toxicity by local anesthetics, only five de-
partments (14 %) reported they would use lipid emul-
sion. Of the remaining departments, 22 (61 %) would
use amiodarone, five (14 %) would use lidocaine, and
four (11 %) would use esmolol. Unfortunately, no data
about the use of electrical cardioversion and its relation
to the use of lipid emulsion in this questionnaire.
In response to convulsions secondary to LAST, only
one respondent (3 %) reported that lipid emulsion would
be the first-line treatment; whereas 25 (69 %) would
choose a benzodiazepine, six (17 %) would use propofol,
three (8 %) would use thiopental, and one (3 %) would
use a muscle relaxant.
None of the 36 respondents reported using lipid
emulsion for severe hypotension (MAP < 60 mmHg).
In contrast, 20 (56 %) would consider epinephrine, 6
(17 %) would choose norepinephrine, five (14 %)
would use dopamine and/or dobutamine, three (8 %)
would use ephedrine, and two (6 %) would choose
phenylephrine.
Discussion
This survey showed that, from September to November
2013, lipid emulsion was available in only 22 % of aca-
demic anesthesiology departments listed by the ortho-
pedic anesthesia group of the CSA. Of the remaining
departments, only 25 % reported intention to stock
lipid emulsion in the near future. The most common
reason for not stocking lipid emulsion by the other 21
Fig. 2 Techniques used by responding institutions for RA. The frequency of utilization of ultrasound differed significantly between high and low
RA-utilization institutions (P = 0.019)
Fig. 3 Adoption of lipid rescue therapy by responding institutions in China in 2013. a Current and future planned availability of lipid emulsion;
b Current availability of lipid emulsion by high and low RA- utilization institutions (P = 1.0); c Future planned availability of lipid emulsion by high
and low RA-utilization institutions (P = 0.394)
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departments was “availability in the central pharmacy”
within the hospital.
The long acting RA preferred by most departments
was ropivacaine, followed by bupivacaine. However,
bupivacaine is more cardiotoxic than similar agents.
Thus, the greater safety of ropivacaine [18] may ex-
plain its widespread and, in some case, exclusive use
by anesthesiologists in many institutions of China.
Other factors, such as the cost of the agent and its
duration of action, may also influence the choice by
anesthesiologists. However, these factors were not
evaluated in our study. Giving a test dose is a safety
step to reduce LAST and was used by all institutions
with 14 % of them using epinephrine-containing test
solutions. Because other safety steps may not prevent
intravascular injection, test dosing with an epinephrine-
containing solution may have value. Any significant
changes in heart rate and blood pressure may alert the
anesthesiologist to intravascular injection of both epi-
nephrine and anesthetic.
Over the past two decades, ultrasound-guided RA
has been increasingly used by anesthesiologists world-
wide. Compared with non-ultrasound techniques,
ultrasound guided RA has been associated with re-
duced rates of inadvertent vascular puncture [19] and
reduced LA requirements [20], resulting in reduction
in the risk and severity of LAST [21]. Half of the re-
spondents to our survey reported using ultrasound
guidance and combined ultrasound and nerve stimulator
guidance. Interestingly, ultrasound guided methods were
more frequently used in low than in high RA-utilization
institutions. The reasons for this difference remain un-
clear. Furthermore, the lower use of ultrasound guid-
ance and higher incidence of LAST in high-utilization
institutions may pointed to the clinical efficacy and safety
of the performance of ultrasound-guided RA. Neverthe-
less, wether there is a negative correlation between use of
ultrasound guidance and LAST or not is not presented in
the current study and requires further research.
As LAST is a rare but devastating complication of RA,
the availability of lipid emulsion is a patient-safety issue
[14]. The AAGBI guidelines recommend that 20 % lipid
emulsion should be “immediately available in all areas
where potentially toxic doses of local anesthetics are ad-
ministered.” All eight departments stocking lipid emul-
sion reported that they could obtain the drug within
5 min. However, many respondents that did not stock
lipid emulsion reported that it was available at their cen-
tral pharmacies. Thus, lipid emulsion was unlikely to be
immediately available to those departments. Because
AAGBI guidelines were not followed, increased phys-
ician awareness and education are warranted.
Our survey also assessed the effectiveness of lipid res-
cue in patients with LAST. Lipid resuscitation was suc-
cessful in 11 of 12 events in the eight departments that
store lipid emulsion. Although we did not assess the cir-
cumstances in which lipid emulsion was used, clinical
and experimental reports have shown failure of lipid res-
cue in LAST management [22–24]. Failures may be due
to the physicochemical properties of local anesthetics,
an inadequate dose of lipid emulsion and/or interaction
between the lipid emulsion and local anesthetics [25].
Optimal methods of administering lipid emulsion have
not yet been determined.
The adoption of LRT in the United Kingdom was
assessed in 2005–2008 by surveying 66 National Health
Service hospitals within London and its surrounding
areas [26]. Following the publication of the 2007
AAGBI guidelines [16], there was a sharp increase in
the number of departments adopting these guidelines.
By 2009, LRT was available in 95.1 % of institutions in
England and Wales [15]. Moreover, two similar national
surveys found that LRT was adopted in 2007 by 49 % of
obstetric anesthesia units in the UK [13] and in 2011 by
88 % of obstetric anesthesia units in the United States
[14]. Our survey found that the overall level of lipid
emulsion availability was much lower, indicating the
need to increase the awareness of LRT throughout
China. Establishing Chinese national guidelines would
likely contribute to this process.
This study had several limitations. As with any survey,
it is subject to responder bias. However, we surveyed 41
academic hospitals that are distributed in all provinces
and major municipalities in mainland China. In addition,
our response rate was 88 %, suggesting that our results
are as representative as possible. Also, we did not report
incidents of local anesthetic toxicity with other fields as
obstetric and peripheral vascular surgeries, in which
lipid emulsion may be more available. However, ortho-
pedic surgery in our study is the major indication for
RA, with the utilization of PNBs in orthopedic surgery
paralleling the increased number of ambulatory surgeries
[27]. Thus, findings in hospitals performing orthopedic
surgery likely reflect the adoption of LRT by aca-
demic anesthesiology departments. Finally, our results
may not reflect the much broader practice of RA in
non-academic departments throughout China.
Table 3 Reasons reported for the unavailability of lipid
emulsion in department of anesthesiology
Reasons n (%)
Availability in center pharmacy 12 (50 %)
A low risk for LAST in the past years 7 (29 %)
Logistical reasons 3 (13 %)
View the LRT with suspicion 1 (4 %)
Unaware of the progress of LRT 1 (4 %)
LAST local anesthetic systemic toxicity, LRT lipid rescue therapy
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Conclusion
The survey found that LRT was available at few aca-
demic anesthesiology departments in China. The safety
of perioperative RA can be optimized by increasing
awareness of LAST and techniques for reducing and
treating this condition. We encourage storage of lipid
emulsion in specified locations, with current guidelines
readily available. To date, no comparable survey has
been reported in other developing countries. Our sur-
vey results may have been somewhat representative,
thereby supporting efforts to globally promote LRT
among practitioners.
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